Ann Hynes
Stock Analyst at Mizuho Securities
(4.65)
# 864
Out of 4,673 analysts
1136
Total ratings
60.1%
Success rate
8.6%
Average return
Main Sectors:
Stocks Rated by Ann Hynes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EHC Encompass Health | Maintained: Buy | $134 → $140 | $120.31 | +16.37% | 42 | Aug 11, 2026 | |
| MD Pediatrix Medical Group | Maintained: Hold | $27 → $28 | $26.57 | +5.38% | 46 | Aug 11, 2026 | |
| CRL Charles River Laboratories International | Maintained: Hold | $230 → $264 | $295.19 | -10.57% | 15 | Aug 10, 2026 | |
| LH Labcorp Holdings | Maintained: Buy | $320 → $355 | $336.34 | +5.55% | 61 | Aug 10, 2026 | |
| THC Tenet Healthcare | Maintained: Buy | $250 → $290 | $280.77 | +3.29% | 54 | Aug 10, 2026 | |
| CON Concentra Group Holdings Parent | Maintained: Buy | $35 → $40 | $35.00 | +14.29% | 11 | Aug 10, 2026 | |
| ARDT Ardent Health | Maintained: Buy | $12 → $13 | $10.99 | +18.29% | 8 | Aug 6, 2026 | |
| IQV IQVIA Holdings | Maintained: Buy | $230 → $275 | $259.82 | +5.84% | 53 | Jul 31, 2026 | |
| FTRE Fortrea Holdings | Maintained: Hold | $16 → $19 | $18.39 | +3.32% | 16 | Jul 31, 2026 | |
| BTSG BrightSpring Health Services | Reiterated: Buy | $86 | $58.87 | +46.08% | 21 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $525 → $475 | $429.19 | +10.67% | 64 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $260 | $244.39 | +6.39% | 65 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $665 | $620.75 | +7.13% | 14 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $470 → $493 | $390.11 | +26.37% | 57 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $27 → $31 | $27.82 | +11.43% | 46 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $63 → $69 | $65.02 | +6.12% | 38 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $115 → $120 | $93.02 | +29.00% | 74 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $390 → $468 | $378.88 | +23.52% | 47 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $215 → $255 | $200.29 | +27.32% | 36 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $230 → $200 | $177.26 | +12.83% | 62 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $465 → $470 | $400.54 | +17.34% | 46 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 → $19 | $14.52 | +30.85% | 17 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $180 → $190 | $172.23 | +10.32% | 53 | Jun 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $330 → $340 | $277.51 | +22.52% | 38 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $318.04 | n/a | 38 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $858.90 | n/a | 52 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $110 | $229.51 | n/a | 43 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $220 | $138.83 | n/a | 1 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $580.63 | n/a | 1 | Sep 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $68.27 | n/a | 1 | Apr 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.5 → $3.6 | $3.01 | n/a | 16 | Jul 27, 2018 |
Encompass Health
Aug 11, 2026
Maintained: Buy
Price Target: $134 → $140
Current: $120.31
Upside: +16.37%
Pediatrix Medical Group
Aug 11, 2026
Maintained: Hold
Price Target: $27 → $28
Current: $26.57
Upside: +5.38%
Charles River Laboratories International
Aug 10, 2026
Maintained: Hold
Price Target: $230 → $264
Current: $295.19
Upside: -10.57%
Labcorp Holdings
Aug 10, 2026
Maintained: Buy
Price Target: $320 → $355
Current: $336.34
Upside: +5.55%
Tenet Healthcare
Aug 10, 2026
Maintained: Buy
Price Target: $250 → $290
Current: $280.77
Upside: +3.29%
Concentra Group Holdings Parent
Aug 10, 2026
Maintained: Buy
Price Target: $35 → $40
Current: $35.00
Upside: +14.29%
Ardent Health
Aug 6, 2026
Maintained: Buy
Price Target: $12 → $13
Current: $10.99
Upside: +18.29%
IQVIA Holdings
Jul 31, 2026
Maintained: Buy
Price Target: $230 → $275
Current: $259.82
Upside: +5.84%
Fortrea Holdings
Jul 31, 2026
Maintained: Hold
Price Target: $16 → $19
Current: $18.39
Upside: +3.32%
BrightSpring Health Services
Jul 31, 2026
Reiterated: Buy
Price Target: $86
Current: $58.87
Upside: +46.08%
Jul 28, 2026
Maintained: Buy
Price Target: $525 → $475
Current: $429.19
Upside: +10.67%
Jul 28, 2026
Maintained: Buy
Price Target: $260
Current: $244.39
Upside: +6.39%
Jul 28, 2026
Maintained: Buy
Price Target: $665
Current: $620.75
Upside: +7.13%
Jul 21, 2026
Maintained: Buy
Price Target: $470 → $493
Current: $390.11
Upside: +26.37%
Jul 13, 2026
Maintained: Hold
Price Target: $27 → $31
Current: $27.82
Upside: +11.43%
Jul 13, 2026
Maintained: Hold
Price Target: $63 → $69
Current: $65.02
Upside: +6.12%
Jul 13, 2026
Maintained: Buy
Price Target: $115 → $120
Current: $93.02
Upside: +29.00%
Jul 13, 2026
Maintained: Buy
Price Target: $390 → $468
Current: $378.88
Upside: +23.52%
Jul 13, 2026
Maintained: Buy
Price Target: $215 → $255
Current: $200.29
Upside: +27.32%
Jul 13, 2026
Maintained: Buy
Price Target: $230 → $200
Current: $177.26
Upside: +12.83%
Jul 13, 2026
Maintained: Buy
Price Target: $465 → $470
Current: $400.54
Upside: +17.34%
Jul 13, 2026
Maintained: Buy
Price Target: $17 → $19
Current: $14.52
Upside: +30.85%
Jun 26, 2026
Maintained: Buy
Price Target: $180 → $190
Current: $172.23
Upside: +10.32%
Jun 8, 2026
Maintained: Buy
Price Target: $330 → $340
Current: $277.51
Upside: +22.52%
Mar 7, 2025
Maintained: Buy
Price Target: n/a
Current: $318.04
Upside: n/a
Nov 6, 2024
Maintained: Hold
Price Target: n/a
Current: $858.90
Upside: n/a
Nov 4, 2024
Rated: Hold
Price Target: $110
Current: $229.51
Upside: n/a
Nov 8, 2022
Maintained: Hold
Price Target: $220
Current: $138.83
Upside: n/a
Sep 12, 2022
Reiterated: Buy
Price Target: n/a
Current: $580.63
Upside: n/a
Apr 11, 2022
Reiterated: Buy
Price Target: n/a
Current: $68.27
Upside: n/a
Jul 27, 2018
Reiterated: Hold
Price Target: $4.5 → $3.6
Current: $3.01
Upside: n/a